Upstream Bio, Stock Target Price and Analyst Consensus
| UPB Stock | 10.72 0.32 2.90% |
The current analyst and expert consensus on Upstream Bio, is Strong Buy, with 2 strong buy opinions. The current projected Upstream Bio, target price consensus is 56.50 with 4 analyst opinions. Check out Macroaxis Advice on Upstream Bio, to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.The most common way Upstream Bio, analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Upstream Bio, executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Upstream Bio,. We encourage you to use your own analysis of Upstream Bio, to validate this buy or sell advice. Upstream Bio, buy-or-sell recommendation module provides average expert sentiment on the projected Upstream Bio, target price to derive its highest and lowest estimates based on projected price volatility of 4.2765.
Lowest Forecast 51.42 | Highest Forecast 62.72 | Target Price 56.5 |
It's important to approach Upstream Bio,'s target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Upstream Bio, Target Price Consensus
Upstream target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Upstream Bio,'s target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most Upstream analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Upstream stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Upstream Bio,, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationUpstream Bio, Target Price Projection
Upstream Bio,'s current and average target prices are 10.72 and 56.50, respectively. The current price of Upstream Bio, is the price at which Upstream Bio, is currently trading. On the other hand, Upstream Bio,'s target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Upstream Bio, Market Quote on 20th of July 2025
Target Price
Analyst Consensus On Upstream Bio, Target Price
Upstream Bio, Analyst Ratings
Upstream Bio,'s analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Upstream Bio, stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Upstream Bio,'s financials, market performance, and future outlook by experienced professionals. Upstream Bio,'s historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Upstream Bio, price targets
Upstream Bio,'s stock target price is an estimate of its future price, usually made by analysts. Using Upstream Bio,'s target price to determine if it is a suitable investment can be done through the following steps:- Look at Upstream Bio,'s target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Upstream Bio,'s stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Upstream Bio, Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Upstream Bio, is a key component of Upstream Bio, valuation and have some predictive power on the future returns of a Upstream Bio,.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Banking Invested over 30 shares | |
 | Adviser Favorites Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Chemicals Invested over 40 shares | |
 | Dividend Beast Invested over 50 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Disruptive Technologies Invested few shares | |
 | Business Services Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Automobiles and Trucks Invested over 50 shares |
Check out Macroaxis Advice on Upstream Bio, to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Please note, the presentation of Upstream Bio,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Upstream Bio,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Upstream Bio,'s management manipulating its earnings.